Screeners
Heatmaps
Trends
News

You're viewing limited data.

Sign up

1 asset

Market news

TypeAll

SortNewest

Assets

PROK

Type

TypeAll

All

Sort

SortNewest

Newest

Filter by asset

ProKidney (PROK) Nears A Pivotal Kidney Therapy Verdict

Sep 11Yahoo Finance

ProKidney director Brian Pereira sells $1.07 million in shares

Aug 21Investing.com

Prokidney Insider Sold Shares Worth $1,067,773, According to a Recent SEC Filing

Aug 20Yahoo Finance

ProKidney: Do-Or-Die Phase 3 Meets A Dwindling Balance Sheet (Rating Downgrade) (PROK)

Aug 14Seeking Alpha

ProKidney (PROK) Gets a Buy from Guggenheim

Detailed price information for Prokidney Corp (PROK-Q) from The Globe and Mail including charting and trades.

Aug 12The Globe and Mail

ProKidney earnings missed, revenue topped estimates

Aug 10Investing.com

ProKidney Corp. (PROK) Reports Q2 Loss, Misses Revenue Estimates

Aug 10Yahoo Finance

ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights

Completed enrollment of patients contributing to the Phase 3 PROACT 1 accelerated approval efficacy analysis, positioning the Company for anticipated pivotal eGFR slope topline results in Q2 2027On track for completion of full enrollment for PROACT 1 in the second half of 2026Appointed Kenneth Locke as Chief Technical Officer, adding more than 25 years of R&D, CMC and supply chain leadership experienceEnded Q2 2026 with $181.6 million in cash and cash equivalents and marketable securities, suppo

Aug 10Yahoo Finance

This is the newest page. Registered accounts read further back.